Tobacco Use and Response to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer.

Curr Oncol · 2022 · PMC9498279 · PMID 36135061

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Subgroup analyses from IMpower 130 and IMpower 131 both showed a trend to improved survival with combination therapy in never and ever smokers, but this was not significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.